US2019233796A1PendingUtilityA1

Generation of Inner Ear Cells

Assignee: MASSACHUSETTS EYE & EAR INFIRMARYPriority: Nov 15, 2006Filed: Feb 11, 2019Published: Aug 1, 2019
Est. expiryNov 15, 2026(~0.3 yrs left)· nominal 20-yr term from priority
Inventors:Albert Edge
A61P 27/16C12N 2501/42C12N 2506/1353C12N 5/062C12N 5/0627
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for generating cells of the inner ear, e.g., hair cells and supporting cells, from stem cells, e.g., mesenchymal stem cells, are provided, as well as compositions including the inner ear cells. Methods for the therapeutic use of the inner ear cells for the treatment of hearing loss are also described.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A method of increasing numbers of differentiated inner ear cells in the ear of a subject, the method comprising:
 generating a differentiated inner ear cell, using a method comprising:   (i) providing a population of mesenchymal stem cells obtained from mammalian bone marrow;   (ii) culturing the mesenchymal stem cell in serum-free medium containing insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF);   (iii) inducing the stem cell by maintaining said cell in medium comprising neurotrophin-3 (NT-3) or brain derived neurotrophic factor (BDNF) for time sufficient to differentiate into a progenitor cell that expresses Sox2, Pax6, nestin, and musashih; and   (iv) culturing the progenitor cell in the presence of a gamma secretase inhibitor, wherein the gamma secretase inhibitor is selected from the group consisting of an arylsulfonamide, a dibenzazepine, a benzodiazepine, N—[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phenylglycine t-butyl ester (DAPT), L-685,458, and MK0752, in an amount and for a time sufficient to produce a differentiated inner ear auditory hair cell that expresses myosin VIIa, and espin and optionally expresses one or more of atonal homolog 1 (Atoh1), or jagged 2, thereby producing a differentiated inner ear auditory hair cell, and   implanting the differentiated inner ear auditory hair cell into the ear of the subject.   
     
     
         3 . The method of  claim 2 , wherein the mesenchymal stem cell is obtained from a subject who has sensorineural hair cell loss. 
     
     
         4 . The method of  claim 2 , wherein the differentiated cell is an inner ear auditory hair cell. 
     
     
         5 . The method of  claim 4 , wherein the inner ear auditory hair cell expresses Atoh1, myosin7a, and epsin.

Join the waitlist — get patent alerts

Track US2019233796A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.